Clinical research employment is evolving as global CROs expand, AI reshapes operational roles, and employers face growing pressure to retain skilled professionals. Yet workforce demographics reveal persistent questions about gender representation, racial diversity, compensation, leadership access, and career mobility. This 2027–2028 analysis examines verified employment figures available through 2026, identifies emerging workforce risks, and provides practical strategies for improving recruitment, retention, and advancement. It also explores how clinical research career pathways, professional certification, and equitable workplace practices can influence the industry's future.
1. Clinical Research Workforce Demographics: The Verified Baseline for 2027–2028
An accurate workforce analysis starts with a fundamental distinction: clinical research workforce demographics describe the professionals conducting trials, while clinical trial participant demographics describe the people enrolled in studies.
These populations serve different analytical purposes. A CRO may recruit participants from diverse communities while employing a relatively homogeneous leadership team. An academic research center may have strong gender representation among coordinators but uneven access to senior scientific positions.
Understanding this distinction is essential when evaluating clinical trial site operations, research workforce development, and clinical project leadership.
Global clinical research employment: what the latest large-scale data establishes
The Association of Clinical Research Organizations (ACRO) published its 2026 State of the Industry Report in March 2026, using information about 2025 operations from 15 member companies.
Global employees
472,000+
ACRO member companies, 2025
United States
125,498
Employees with reported location
India
48,794
Employees with reported location
United Kingdom
15,061
Employees with reported location
Published in 2026 using 2025 data. These are member-company employment figures, including multiple business functions, and exclude employers outside the reporting group.
The report also identified 12,582 employees in China and substantial staffing across other regions. Approximately 162,000 employees lacked specified geographic locations in the report, limiting country-level comparisons.
These figures demonstrate the international reach of clinical research services. They also illustrate why employment forecasts should account for organizational coverage and data completeness.
For people comparing CRO versus sponsor employment, exploring global clinical research opportunities, or considering site-to-CRO career transitions, location-specific hiring conditions matter more than worldwide employee totals alone.
Gender, race, education, and compensation: findings from academic research centers
A 2025 peer-reviewed study published in the Journal of Clinical and Translational Science examined responses from 484 clinical research professionals working across three major US academic medical centers.
The respondents' characteristics provide useful evidence about an important section of the workforce.
86% identified as female, compared with 11% who identified as male.
81% identified as White, while 93% identified as non-Hispanic.
34% were between 26 and 35 years old.
53% worked as clinical research coordinators or research nurses.
21% were clinical research managers or directors.
31% reported holding professional certification.
The median reported annual salary category was $65,000–$75,000.
The study achieved a 22.8% response rate, and its sample came from three academic medical centers. Its findings should be interpreted as respondent characteristics within that setting. They cannot establish universal gender, racial, or compensation percentages for the global clinical research industry.
Nevertheless, the study raises meaningful questions about progression from clinical research coordinator jobs into clinical trial management, along with the influence of certification and practical experience.
Representation in scientific trial leadership
A separate 2026 analysis of 88 high-impact interventional structural heart disease trials identified substantial gender disparities in leadership.
Women occupied approximately 7% of trial leadership positions, while 56% of the oversight committees examined had no women members.
These findings apply to a specific cardiology research specialty and leadership setting. Their implications are particularly significant because women represented a substantial proportion of clinical research professionals in the separate academic-center survey.
The two studies measure different populations, so their percentages cannot be combined into a single industry-wide promotion rate. Together, they justify closer investigation of advancement, sponsorship, specialty representation, and leadership selection.
Organizations should examine who gains access to clinical research project management, principal investigator responsibilities, and medical leadership pathways.
The 2027–2028 question is whether organizations can demonstrate measurable improvements in career access, compensation, retention, and leadership advancement. Future workforce counts and demographic shares should be reported when verified data become available, rather than presented as established forecasts.
| Clinical Research Workforce 2027–2028: 36-Indicator Diversity, Equity & Inclusion Scorecard | |||
|---|---|---|---|
| Workforce Indicator | Measurement Method | Warning Signal | Management Response |
| 1. Total workforce | Active headcount and full-time equivalents by year | Headcount growth hides understaffed teams | Report employees and FTEs separately. |
| 2. Geography distribution | Employees by country, region and work location | Large location-unclassified population | Improve location data before comparing regions. |
| 3. Gender representation | Voluntarily reported distribution by role and grade | Uneven representation at higher grades | Review advancement pathways and selection criteria. |
| 4. Racial representation | Lawfully collected, voluntarily reported groups by role | Large gaps across career levels | Examine access barriers and fair employment practices. |
| 5. Ethnicity distribution | Relevant local reporting categories and disclosure rate | Inconsistent categories across countries | Use locally appropriate classification standards. |
| 6. Age distribution | Age bands by job family and seniority | Career access clustered in narrow age groups | Audit experience requirements and career transitions. |
| 7. Disability inclusion | Accessibility audit and confidential accommodation outcomes | Repeated inaccessible recruitment or training | Improve accessibility and accommodation processes. |
| 8. Data disclosure quality | Known responses divided by eligible respondents | Misleading comparisons due to missing information | Publish denominators and nonresponse rates. |
| 9. Entry-level openings | True junior vacancies divided by all advertised roles | Entry-level jobs require prior research employment | Develop supervised trainee and assistant positions. |
| 10. Application conversion | Shortlisted applicants divided by applicants, by role | Large unexplained screening differences | Validate job criteria and structured screening. |
| 11. Interview progression | Finalists divided by interviewed applicants | Uneven conversion after interviews | Use anchored questions and documented scoring. |
| 12. Offer acceptance | Accepted offers divided by valid offers | Candidates reject compensation or job conditions | Review salary bands, workload and transparency. |
| 13. Time to hire | Median days from application to accepted offer | Long delays exclude candidates with less financial flexibility | Set accountable hiring-stage deadlines. |
| 14. Salary starting point | Starting salary by role, grade, region and experience | Inconsistent pay for comparable new hires | Apply objective placement rules within salary bands. |
| 15. Adjusted pay differences | Compare compensation controlling for legitimate job factors | Unexplained pay disparities remain after review | Investigate and correct unsupported differences. |
| 16. Overtime burden | Extra hours per FTE by role and team | Persistent workload concentration | Rebalance staffing and operational assignments. |
| 17. Travel burden | Travel nights and required visits per CRA | Unpredictable or uneven field workload | Review portfolio allocation and travel policies. |
| 18. Training access | Employees receiving approved development opportunities | Training limited to selected teams | Publish eligibility and application procedures. |
| 19. Certification support | Funding and protected study time by career level | Development depends on personal financial resources | Provide transparent learning assistance. |
| 20. Mentorship access | Employees matched with qualified mentors | New hires lack career guidance | Offer structured mentorship and participation tracking. |
| 21. Sponsorship access | Access to high-visibility projects and senior advocates | Advancement relies on informal networks | Document project-selection and development criteria. |
| 22. Promotion eligibility | Eligible employees by grade and performance standards | Qualified staff remain outside review pools | Standardize promotion eligibility rules. |
| 23. Promotion rate | Promoted eligible employees divided by eligible employees | Persistent unexplained differences | Audit performance evidence and panel decisions. |
| 24. Time to promotion | Median time in grade before progression | Different waiting periods for comparable employees | Review role criteria and career-ladder transparency. |
| 25. Leadership composition | Representation by management and executive level | Representation drops sharply with seniority | Examine succession and leadership selection. |
| 26. Trial leadership access | Study leadership and committee roles by specialty | Qualified specialists excluded from key appointments | Use transparent expertise-based nomination processes. |
| 27. Voluntary turnover | Voluntary departures divided by average headcount | Disproportionate departures from critical roles | Review compensation, workload and exit feedback. |
| 28. First-year retention | New hires remaining employed after 12 months | Early exits linked to inadequate onboarding | Improve supervision, expectations and job previews. |
| 29. Flexible work access | Eligibility and uptake by operational role | Inconsistent accommodations or flexibility rules | Define role-appropriate flexibility transparently. |
| 30. Parental leave outcomes | Return and 12-month retention after leave | Repeated attrition after family-related leave | Review leave support and return-to-work plans. |
| 31. Employee voice | Confidential survey findings and response rate | Low trust or repeated unresolved concerns | Publish actions and track their completion. |
| 32. Complaint resolution | Resolution times and procedural fairness | Reports remain unresolved or retaliation concerns emerge | Use independent, confidential escalation channels. |
| 33. AI training availability | Access to validated AI and digital workflow training | Technology change disadvantages certain teams | Provide role-specific retraining and competency checks. |
| 34. Technology impact | Tasks automated, redeployment and quality outcomes | Role displacement without transition support | Offer redeployment pathways and document controls. |
| 35. Community recruitment capacity | Languages, outreach experience and local site capability | Participants face communication or access barriers | Train appropriate personnel and improve accessible outreach. |
| 36. Data governance and privacy | Consent, permitted use, group size and access controls | Sensitive information exposed in small-group reports | Aggregate, restrict and suppress identifiable data. |
2. Where Workforce Diversity and Career Equity Gaps Are Most Likely to Appear
A workforce can appear diverse at the organizational level while showing substantial differences between entry-level positions, specialist functions, and executive leadership.
For 2027–2028, meaningful analysis requires separating job families and comparing employees with similar qualifications, responsibilities, experience, and working conditions.
Entry-level roles: access to the first clinical research job
Clinical research remains difficult to enter when employers request prior trial experience for supposedly junior positions.
Applicants pursuing research assistant careers without experience may face a hiring barrier that disproportionately affects candidates without professional networks, unpaid internship opportunities, or the financial resources for prolonged job searching.
A more accessible pipeline starts by differentiating tasks that require substantial experience from those that can be learned through supervised training.
For example, site document coordination, appointment support, and basic trial logistics can provide early exposure when responsibilities are properly assigned and supervised. These activities align with research assistant training, trial logistics responsibilities, and clinical research team communication.
Organizations should measure applicant conversion at every recruitment stage. A large applicant pool provides limited insight when qualified candidates are screened out by requirements unrelated to actual job performance.
Coordinators and research nurses: career ladders and workload
Clinical research coordinators handle protocol execution, participant scheduling, documentation, and coordination across study teams. Some have substantial regulatory and operational responsibilities without equivalent authority over staffing or budgets.
Organizations should compare coordinator pay, workload, training access, and promotion eligibility against the complexity of assigned studies.
Employees managing demanding oncology trials may face different workloads from those supporting less intensive observational research. A useful CRC career analysis accounts for protocol complexity, participant volume, specialty, and responsibility.
Career progression should also offer documented routes into clinical trial management from a CRC position, project management training, and site operations leadership.
Without transparent requirements, employees may remain in demanding operational positions even after demonstrating readiness for broader responsibilities.
CRAs: compensation, travel, and lifestyle barriers
Field monitoring presents a different equity challenge.
Clinical research associate roles can involve substantial travel, unpredictable schedules, overnight assignments, and workload expectations measured through visit completion and study deliverables.
These conditions may be especially difficult for employees with caregiving responsibilities, health-related accommodation needs, or limited access to transportation.
A fair assessment compares travel burden, compensation, promotion opportunities, and role expectations among employees holding similar positions.
Professionals evaluating CRA travel and burnout, CRA salaries, and CRO versus sponsor opportunities should investigate the operational requirements attached to each offer.
Organizations can review whether travel assignments are distributed consistently and whether less travel-intensive pathways are available where the work permits.
Pharmacovigilance and data operations: access to emerging technical roles
Drug safety, clinical data management, and regulatory operations are increasingly affected by automated workflows.
Employees who already possess specialized technical knowledge may be better positioned to transition into system validation, medical review, data governance, and quality oversight.
Those assigned repetitive processing activities could face greater retraining needs.
The relevant workforce question is whether access to new skills is determined by transparent competency requirements or informal managerial preferences.
Organizations should offer development opportunities aligned with AI-related pharmacovigilance changes, clinical research automation exposure, and pharmacovigilance career advancement.
Scientific and medical leadership: advancement barriers
Medical monitors, medical science liaisons, principal investigators, and clinical program directors generally have different qualification pathways.
A person progressing from clinical operations into senior management faces different requirements from a physician pursuing responsibility for medical safety oversight.
An effective equity assessment considers each profession's qualifications while evaluating whether hiring and advancement decisions apply those standards consistently.
For example, investigate how candidates obtain mentorship, publication opportunities, leadership experience, and access to influential projects.
These factors are particularly relevant to medical monitor versus MSL pathways, MSL qualifications without a PhD, and clinical research leadership development.
3. Clinical Research Workforce Trends and Outlook for 2027–2028
The next two years could change how clinical research organizations recruit, train, and promote employees. Several developments are already visible through 2026, although their effects on future workforce demographics remain uncertain.
A responsible outlook separates published projections from emerging operational trends and outcomes that require future measurement.
Employment demand: growth potential differs by occupation
The US Bureau of Labor Statistics projects 13% employment growth for medical scientists between 2025 and 2035, with approximately 10,500 annual openings on average over the decade.
This projection applies to the broader medical scientist occupation. It should not be interpreted as a direct forecast for clinical research coordinators, CRAs, or research assistants.
BLS does not publish a separate national employment forecast for every specialized clinical research role.
Employers forecasting 2027–2028 hiring should therefore combine occupational projections with local vacancy data, site workload, trial portfolios, and expected staffing replacements.
For candidates examining entry-level clinical research hiring, CRA employment prospects, and clinical project management careers, role-specific employer demand is more useful than a single industry growth percentage.
AI could widen or reduce workforce opportunity gaps
ACRO's 2026 industry reporting documents applications of AI across study feasibility, site selection, protocol optimization, data management, document authoring, and operational workflows.
By 2027–2028, expanded automation could create demand for new combinations of regulatory knowledge, system oversight, data interpretation, and clinical judgment.
Three outcomes are worth monitoring:
Skills concentration: Employees with early access to digital training advance faster than equally capable colleagues without such opportunities.
Career transition: Repetitive tasks become automated while new positions emerge in validation, oversight, exception management, and quality assurance.
Workload redistribution: Automation reduces administrative effort in some functions while creating additional review responsibilities elsewhere.
These are plausible scenarios rather than measured future outcomes.
For clinical data and monitoring professionals, pharmacovigilance workers, and clinical trial project managers, the opportunity lies in combining specialized domain knowledge with responsible technology use.
Organizations should measure who receives AI training, which roles are redesigned, and whether affected employees receive opportunities to qualify for new responsibilities.
Global recruitment could create new career mobility barriers
International clinical research operations may benefit from broader recruitment markets and geographically distributed teams.
However, expanding recruitment across borders introduces questions about local qualifications, language proficiency, compensation, employment protections, and professional development.
Foreign-trained physicians, internationally educated nurses, and biotechnology professionals transitioning after layoffs may bring valuable clinical or scientific experience while encountering unfamiliar hiring requirements.
Organizations can strengthen recruitment by reviewing qualifications individually and applying legitimate role-specific requirements consistently.
This is relevant to foreign-trained doctors entering US clinical research, nurses changing careers, and biotechnology professionals transitioning into research.
Regulatory and policy developments require careful interpretation
ICH E6(R3) emphasizes quality by design, proportionate risk management, qualified personnel, and reliable trial data. The European Medicines Agency lists January 15, 2027, as the effective date for the consolidated E6(R3) guideline and Annex 2 in the EU.
These changes may influence training needs, particularly for workers supporting innovative trial designs, decentralized methods, and technology-enabled studies.
Separately, the FDA's December 2025 guidance on enhancing clinical trial participation addresses enrollment practices and representative study populations.
Participant representation requirements and employment diversity practices operate under different legal frameworks. Clinical research organizations should distinguish scientific recruitment objectives from workplace hiring, promotion, and demographic data collection.
US DEI policy has also undergone changes, making jurisdiction-specific legal review important. Employers should maintain lawful, consistently applied employment practices and verify current requirements rather than assuming a single global DEI standard.
The workforce implications connect to GCP training expectations, ICH E6(R3) professional competencies, and clinical research compliance.
Three practical scenarios for 2027–2028
Improvement scenario: Organizations expand supervised entry pathways, transparently allocate training, and standardize promotion criteria. Hiring conversion and retention improve across previously underserved employee groups.
Uneven-progress scenario: Organizations increase hiring but leave workload, compensation, and leadership selection practices unchanged. Entry-level representation improves while advancement disparities persist.
Workforce-pressure scenario: Cost reductions, uneven AI adoption, and site staffing shortages limit development opportunities. Turnover rises among employees with the fewest alternatives or greatest operational burden.
Employers should test these scenarios against quarterly evidence rather than assign unsupported probabilities.
A useful workforce dashboard connects clinical trial staffing demands, career mobility, and project quality outcomes.
What Is the Biggest Barrier to Building a Fairer Clinical Research Workforce by 2028?
Choose the challenge you see most often and reveal a practical response.
Audit job descriptions for unnecessary experience requirements. Introduce supervised trainee positions, structured skills assessments, and transparent training pathways. Measure interview conversion and first-year retention rather than applicant volume alone.
Compare pay, protocol complexity, travel nights, overtime, and turnover within equivalent roles. Investigate unexplained differences and define staffing interventions for teams experiencing persistent overload.
Publish competency requirements for promotion, establish structured review panels, and document how leadership assignments are awarded. Track eligibility, promotion rates, and time in grade to identify inconsistent progression.
Create transparent access to funded certification, protected learning time, mentorship, and validated digital-skills training. Measure participation by role, employment location, and seniority while maintaining lawful privacy protections.
Track hiring conversion, compensation, promotion eligibility, first-year retention, and employee feedback with clear denominators. Assign owners and improvement deadlines. Protect sensitive information and report progress using appropriately aggregated results.
4. How Clinical Research Organizations Can Improve Workplace Equity and Inclusion
Organizations seeking stronger workforce outcomes in 2027–2028 need practical processes covering recruitment, compensation, career development, and retention.
Successful interventions require clear ownership, measurable results, and compliance with relevant employment and privacy laws.
Establish competency-based recruitment
Clinical research hiring often relies on credentials, job titles, and previous employer names as screening signals.
These indicators can be useful, but they should be evaluated against the actual requirements of the role.
For example, a clinical research assistant position requiring introductory protocol knowledge could reasonably assess a candidate's ability to interpret study instructions, identify documentation errors, and communicate appropriately with site personnel.
A candidate with nursing, laboratory, pharmacy, or administrative experience may demonstrate relevant competencies without having previously held a clinical trial job.
Employers can evaluate these capabilities using structured interviews and standardized work samples.
This helps address the barriers explored in clinical research certification versus experience, research assistant career preparation, and entry-level clinical research resume development.
Examine compensation within comparable roles
A meaningful compensation audit should control for legitimate differences such as job level, geographic market, responsibilities, qualifications, and relevant experience.
Suppose two coordinators manage comparable protocols but receive different compensation. Review whether the difference reflects documented job factors or inconsistent salary-setting practices.
Compare base pay, bonuses, overtime, travel reimbursement, training benefits, and promotion history when relevant.
Avoid comparing salaries across unrelated positions without adjusting for responsibilities. The compensation structure for a clinical research associate differs from that of a pharmacovigilance professional or medical science liaison.
The objective is to identify unjustified differences among employees performing comparable work.
Create transparent internal advancement pathways
Employees should understand which competencies are required to move from junior research positions to senior coordination, monitoring, operations management, or specialist roles.
A structured career framework might include documented expectations for protocol knowledge, quality management, regulatory responsibilities, communication, project oversight, and staff leadership.
For example, a coordinator seeking project management responsibilities could demonstrate experience with milestone tracking, operational risk reviews, cross-functional meetings, and issue escalation.
That progression connects CRC-to-clinical-trial-manager transitions, trial milestone management, and clinical trial project leadership.
Promotion decisions should be supported by defined criteria, consistent evaluation, and documented performance evidence.
Make professional development accessible
Training costs, scheduling restrictions, and limited managerial support can affect who gains advanced qualifications.
Organizations should examine whether development funding reaches employees across different grades, locations, and operational functions.
A transparent training policy can define eligibility for certification reimbursement, protected learning time, mentorship, and job-related continuing education.
Development opportunities may include GCP certification training, pharmacovigilance preparation, project management competencies, and free clinical research learning resources.
Organizations should measure subsequent competency development and career progression alongside training participation.
Improve retention through operational changes
Retention problems may emerge from workloads, insufficient staffing, limited advancement, compensation, or poor management practices.
The 2025 academic-center workforce study identified work complexity and stress, salary and benefits, and professional development among important job satisfaction themes.
Employers should investigate which concerns are most influential within each job family.
For clinical research coordinators, excessive protocol volume and inadequate staffing may be important. For CRAs, travel intensity and portfolio stability can affect job satisfaction. For pharmacovigilance teams, unpredictable safety-processing workloads may influence retention.
Review CRA work-life balance, clinical research team management, and clinical trial site operations to connect workforce retention with operational practices.
Privacy safeguards should accompany every demographic initiative. Sensitive employee information should be collected only where lawful and appropriate, with secure access and sufficiently aggregated reporting to prevent identification.
5. A Practical 2027–2028 Workforce Equity Action Plan for CROs and Research Sites
Organizations can translate demographic analysis into practical improvements using a phased workforce assessment.
The process should address access, performance, compensation, and retention while avoiding misleading statistics or unsupported conclusions.
First 30 days: establish a reliable baseline
Begin with current headcount and full-time equivalent staffing across clinical sites, CRO operations, sponsors, and other relevant departments.
Segment employees by job family, grade, location, tenure, and employment arrangement. Incorporate voluntarily disclosed demographic information only where its collection and use are lawful.
Use consistent definitions for clinical research coordinators, research nurses, CRAs, data management specialists, pharmacovigilance workers, and management roles.
Calculate missing-data rates before reporting demographic percentages. A leadership diversity figure based on incomplete records may give a distorted picture.
For organizations overseeing clinical research site operations, CRO workforces, and clinical research project teams, consistent employment categories are essential for credible comparisons.
Days 31–60: investigate the largest workforce barriers
Review the employee lifecycle using four critical measures.
Hiring conversion: Divide candidates progressing to a specified recruitment stage by those eligible at the previous stage. Investigate differences after accounting for job-related criteria and application quality.
Promotion rate: Divide promotions by the number of employees eligible for advancement. Compare employees within equivalent grades and responsibilities.
First-year retention: Divide new hires remaining after 12 months by the relevant starting cohort, accounting for observation periods and employment status.
Compensation differences: Compare pay among appropriately matched roles, adjusting for legitimate job-related factors.
A useful analysis also incorporates employee interviews, confidential feedback, training access, and operational workload information.
Organizations should distinguish issues affecting first-time clinical research applicants from those affecting experienced clinical coordinators and senior clinical research managers.
Days 61–90: implement targeted changes
Select a small number of interventions supported by the findings.
A site facing high coordinator turnover may revise staffing allocation, introduce a senior coordinator progression pathway, and improve paid training access.
A CRO experiencing uneven CRA advancement may standardize promotion criteria, document portfolio assignments, and provide transparent access to development projects.
A sponsor identifying gaps in leadership selection may review how qualified professionals gain access to medical governance, project leadership, and trial oversight opportunities.
Each intervention should have an owner, implementation deadline, measurable outcome, and scheduled review.
This approach is consistent with the operational discipline used in clinical research quality management, project milestone management, and team leadership.
What to measure throughout 2027 and 2028
2027 priorities: Establish consistent quarterly reporting, complete compensation reviews, identify workforce skill gaps created by automation, and implement measurable recruitment and advancement improvements.
2028 priorities: Assess whether interventions produced sustained improvements in employee retention, career progression, workplace accessibility, and operational performance.
For each measure, compare results against the organization's own 2026 baseline and appropriate external benchmarks where available.
Use consistent employee populations and methodologies. Changes in mergers, outsourcing, reporting boundaries, and voluntary disclosure can affect apparent demographic trends.
For example, an increase in the percentage of employees from a particular demographic group may reflect improved representation, a change in reporting coverage, or a higher survey response rate. The underlying cause requires investigation.
A useful annual report should explain measurement methods, material data limitations, actions completed, unresolved issues, and the next review date.
The goal is to establish whether fair employment practices are translating into stronger career opportunities, improved employee experiences, and a stable workforce capable of delivering high-quality clinical research.
6. Frequently Asked Questions About Clinical Research Workforce Diversity in 2027–2028
-
A verified global clinical research workforce total for 2028 is not yet available.
ACRO's March 2026 industry report identified more than 472,000 employees across its reporting member organizations, using 2025 data. The figure covers a substantial portion of the clinical research services industry but excludes many employers outside the reporting group.
Future workforce estimates should account for pharmaceutical sponsors, independent sites, academic institutions, technology providers, and changes in reporting coverage.
Professionals evaluating global career opportunities, CRO employment, and clinical research career pathways should prioritize verified regional and occupational data.
-
The percentage varies by country, employer, and occupational category.
A 2025 study involving 484 clinical research professionals at three US academic medical centers found that 86% of survey respondents identified as female.
That percentage describes the study respondents and should not be used as a worldwide workforce estimate.
Organizations should evaluate gender representation separately across research assistant positions, CRC career pathways, and clinical project management roles.
-
Some specialty-specific studies identify substantial disparities.
A 2026 analysis of 88 interventional structural heart disease trials found that women occupied approximately 7% of trial leadership positions, and 56% of examined oversight committees included no women.
The findings describe a specific research specialty and cannot establish an industry-wide percentage.
Organizations should evaluate leadership qualifications, mentorship opportunities, access to influential assignments, and transparent advancement procedures.
This matters for clinical trial project management, investigator responsibilities, and medical leadership careers.
-
Important concerns include limited entry-level opportunities, inconsistent qualification requirements, uneven access to professional networks, inaccessible recruitment processes, and unclear salary practices.
Employers should examine how candidates progress through screening, interviews, offers, and onboarding.
A practical intervention is replacing unnecessary experience requirements with role-relevant skills assessments and supervised training opportunities.
Candidates can strengthen their preparation through clinical research resume development, entry-level research career guidance, and research assistant training.
-
Both outcomes are plausible, depending on how organizations implement new technologies.
AI may create opportunities in quality assurance, data review, regulatory systems, and clinical oversight. It may also increase barriers for employees who lack access to relevant training.
Employers should track AI training participation, task automation, internal mobility, and employee outcomes.
Understanding AI exposure across clinical research jobs, pharmacovigilance automation, and ICH E6(R3) quality expectations can help organizations design effective retraining programs.
-
CROs should compare employees performing comparable work while accounting for legitimate differences in grade, responsibilities, qualifications, experience, geography, and relevant compensation factors.
The analysis should examine base salary and other applicable compensation components, including bonuses and allowances.
Unexplained differences require further investigation and appropriate corrective action.
Pay reviews should use reliable employment records and privacy safeguards.
Professionals comparing CRA salary structures, pharmacovigilance compensation, and CRO versus sponsor employment should consider role expectations alongside salary figures.